Publication at First Faculty of Medicine, Faculty of Medicine in Hradec Králové |
2016
Abstract
Sclerostin (the SOST gene product) is a circulating inhibitor of Wnt/beta-catenin signaling pathway produced mainly osteocytes, which negatively affects osteoblastogenezi, thereby inhibiting hematopoiesis bone and contributes significantly to the development of osteoporosis.